Carolina Liquid Chemistries launches FDA-cleared test for hydrocodone test screens

Sept. 3, 2014

According to the Centers for Disease Control and Infection (CDC), more people die in America every year from prescription drug abuse than from heroin and cocaine combined. As part of its efforts to address the need for prescription drug abuse testing, Carolina Liquid Chemistries Corp. has launched an FDA-cleared hydrocodone urine test. The test can be run in minutes on chemistry analyzers in a physician office, hospital, or reference laboratory.

This test is a homogeneous enzyme immunoassay intended for both the qualitative and semi-quantitative determination of hydrocodone at 100ng/mL or 300ng/mL cut-off. Controls and calibrators are available to accommodate the cut-off. This assay, with minimal cross-reactivity, provides a rapid screen for the presence of hydrocodone and hydromorphone in urine.

Carolina’s announcement coincides with the federal government finalizing new rules on prescribing hydrocodone medication, such as Vicodin, Lortab, and their generic equivalents. Patients will be limited to one 90-day supply of medication and will be required to see a healthcare professional to get a refill.

“In July, the vitamin D test on our CLC720 chemistry analyzer was launched; one month to the date we are launching hydrocodone for chemistry analyzers,” says Phil Shugart, CEO. “Newer chemistry analyzers are excellent platforms for these innovative tests. It is exciting to see the work of our colleagues come to fruition; it is a privilege to bring these much needed, ‘easy to use’ tests to market.” Learn more about products offered by Carolina Liquid Chemistries.

Read more